165 related articles for article (PubMed ID: 37944999)
1. Biliary Tract Cancer: Molecular Biology of Precursor Lesions.
Manzano-Núñez F; Prates Tiago Aguilar L; Sempoux C; Lemaigre FP
Semin Liver Dis; 2023 Nov; 43(4):472-484. PubMed ID: 37944999
[TBL] [Abstract][Full Text] [Related]
2. Histological features of precancerous and early cancerous lesions of biliary tract carcinoma.
Aishima S; Kubo Y; Tanaka Y; Oda Y
J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):448-52. PubMed ID: 24446428
[TBL] [Abstract][Full Text] [Related]
3. p53 protects against formation of extrahepatic biliary precancerous lesions in the context of oncogenic Kras.
Nagao M; Mizukoshi K; Nakayama S; Namikawa M; Hiramatsu Y; Maruno T; Nakanishi Y; Tsuruyama T; Fukuda A; Seno H
Oncotarget; 2023 Mar; 14():276-279. PubMed ID: 36999984
[No Abstract] [Full Text] [Related]
4. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.
Kasuga A; Semba T; Sato R; Nobusue H; Sugihara E; Takaishi H; Kanai T; Saya H; Arima Y
Cancer Sci; 2021 May; 112(5):1822-1838. PubMed ID: 33068050
[TBL] [Abstract][Full Text] [Related]
5. Precancerous lesions of the biliary tree.
Klöppel G; Adsay V; Konukiewitz B; Kleeff J; Schlitter AM; Esposito I
Best Pract Res Clin Gastroenterol; 2013 Apr; 27(2):285-97. PubMed ID: 23809246
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma?
Bickenbach K; Galka E; Roggin KK
Surg Oncol Clin N Am; 2009 Apr; 18(2):215-24, vii. PubMed ID: 19306808
[TBL] [Abstract][Full Text] [Related]
7. Defining the biology of intrahepatic cholangiocarcinoma: molecular pathways and early detection of precursor lesions.
Gibiino G; Fabbri C; Fagiuoli S; Ianiro G; Fornelli A; Cennamo V
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):730-741. PubMed ID: 28272710
[TBL] [Abstract][Full Text] [Related]
8. Updates on Precancerous Lesions of the Biliary Tract: Biliary Precancerous Lesion.
Ainechi S; Lee H
Arch Pathol Lab Med; 2016 Nov; 140(11):1285-1289. PubMed ID: 27788047
[TBL] [Abstract][Full Text] [Related]
9. Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma.
Hansel DE; Meeker AK; Hicks J; De Marzo AM; Lillemoe KD; Schulick R; Hruban RH; Maitra A; Argani P
Mod Pathol; 2006 Jun; 19(6):772-9. PubMed ID: 16557277
[TBL] [Abstract][Full Text] [Related]
10. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
[TBL] [Abstract][Full Text] [Related]
11. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
12. Cholangiocarcinoma: a pathologists point of view.
Hrudka J; Sticová E
Rozhl Chir; 2022; 101(10):478-487. PubMed ID: 36402559
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis.
Goeppert B; Stichel D; Toth R; Fritzsche S; Loeffler MA; Schlitter AM; Neumann O; Assenov Y; Vogel MN; Mehrabi A; Hoffmann K; Köhler B; Springfeld C; Weichenhan D; Plass C; Esposito I; Schirmacher P; von Deimling A; Roessler S
Gut; 2022 Feb; 71(2):391-401. PubMed ID: 33468537
[TBL] [Abstract][Full Text] [Related]
14. Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers.
Itoi T; Shinohara Y; Takeda K; Nakamura K; Shimizu M; Ohyashiki K; Hisatomi H; Nakano H; Moriyasu F
Int J Mol Med; 2001 Mar; 7(3):281-7. PubMed ID: 11179508
[TBL] [Abstract][Full Text] [Related]
15. Precancerous lesions of the biliary tree.
Callea F; Sergi C; Fabbretti G; Brisigotti M; Cozzutto C; Medicina D
J Surg Oncol Suppl; 1993; 3():131-3. PubMed ID: 8389160
[TBL] [Abstract][Full Text] [Related]
16. [Intraductal papillary neoplasms of the bile duct (IPNB). Diagnostic criteria, carcinogenesis and differential diagnostics].
Schlitter AM; Klöppel G; Esposito I
Pathologe; 2013 Nov; 34 Suppl 2():235-40. PubMed ID: 24196621
[TBL] [Abstract][Full Text] [Related]
17. Extensive biliary intraepithelial neoplasia (BilIN) and multifocal early intrahepatic cholangiocarcinoma in non-biliary cirrhosis.
Rougemont AL; Genevay M; McKee TA; Gremaud M; Mentha G; Rubbia-Brandt L
Virchows Arch; 2010 Jun; 456(6):711-7. PubMed ID: 20428886
[TBL] [Abstract][Full Text] [Related]
18. [Gallbladder and bile duct carcinoma. Biology and pathology].
Tannapfel A; Wittekind C
Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
[TBL] [Abstract][Full Text] [Related]
19. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
[TBL] [Abstract][Full Text] [Related]
20. Pathology of cholangiocellular carcinoma.
Hrudka J; Oliverius M; Gürlich R
Cas Lek Cesk; 2019; 158(2):57-63. PubMed ID: 31109164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
